LivePerson (LPSN) director Ryan Vardeman granted 23,350 restricted stock units

Rhea-AI Filing Summary

LivePerson director Ryan L. Vardeman reported an award of 23,350 restricted stock units on December 10, 2025. Each RSU represents a contingent right to receive one share of LivePerson common stock and will fully vest on December 10, 2026. The grant was made at a price of $0, reflecting stock-based compensation rather than an open-market purchase. Following this grant, Vardeman beneficially owns 23,350 shares directly through unvested RSUs and 44,422 additional shares indirectly through Palogic investment entities, as described in the ownership footnotes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vardeman Ryan L.

(Last) (First) (Middle)

C/O LIVEPERSON, INC.

530 7TH AVE., FLOOR M1

(Street)

NEW YORK NY 10018

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LIVEPERSON INC [ LPSN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		A		23,350(1)	A	$0	23,350(2)	D
Common Stock								44,422	I	See Footnotes(3)(4)(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person was granted an award of restricted stock units under the terms of the LivePerson, Inc. 2019 Stock Incentive Plan consisting of a grant of 23,350 restricted stock units (the "RSUs"), each of which represents a contingent right to receive one share of common stock of the issuer. These RSUs will fully vest on December 10, 2026.

2. Number reported includes 23,350 unvested restricted stock units granted to and held by the reporting person following the reported transaction.

3. This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund.

4. The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended.

5. The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

Remarks:

	/s/ Monica L. Greenberg, Attorney-in-Fact for Ryan L. Vardeman	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LivePerson (LPSN) report for Ryan Vardeman?

Ryan Vardeman received an award of 23,350 restricted stock units of LivePerson common stock on December 10, 2025. The RSUs were granted at a price of $0 as stock-based compensation.

When do Ryan Vardeman’s LivePerson (LPSN) restricted stock units vest?

The 23,350 restricted stock units fully vest on December 10, 2026, after which each unit entitles him to receive one share of LivePerson common stock.

How many LivePerson (LPSN) shares does Ryan Vardeman beneficially own after this transaction?

After the reported award, Vardeman beneficially owns 23,350 shares directly through unvested RSUs and 44,422 shares indirectly through Palogic investment entities.

What is Ryan Vardeman’s role at LivePerson (LPSN)?

The report identifies Ryan L. Vardeman as a director of LivePerson Inc., making him an insider subject to Section 16 reporting requirements.

Through which entities does Ryan Vardeman have indirect ownership of LivePerson (LPSN) shares?

Indirect ownership is attributed through Palogic Value Fund, L.P., its general partner Palogic Value Management, L.P., and Palogic Capital Management, LLC, of which Vardeman is the sole member and also a limited partner in Palogic Value Fund.

What price was assigned to the restricted stock units granted to Ryan Vardeman at LivePerson (LPSN)?

The 23,350 restricted stock units were reported with a price of $0, consistent with a compensatory equity grant rather than a market purchase.